A DOMINANT-NEGATIVE BONE MORPHOGENETIC PROTEIN-4 RECEPTOR CAUSES NEURALIZATION IN XENOPUS ECTODERM

被引:108
|
作者
XU, RH
KIM, JB
TAIRA, M
ZHAN, SI
SREDNI, D
KUNG, HF
机构
[1] NCI,FREDERICK CANC RES & DEV CTR,BIOL RESPONSE MODIFIERS PROGRAM,BIOCHEM PHYSIOL LAB,FREDERICK,MD 21702
[2] NICHHD,GENET MOLEC LAB,BETHESDA,MD 20892
[3] NCI,FREDERICK CANC RES & DEV CTR,VIRAL CARCINOGENESIS LAB,CBS,FREDERICK,MD 21702
[4] BAR ILAN UNIV,INTERDISCIPLINARY DEPT,IL-52900 RAMAT GAN,ISRAEL
关键词
D O I
10.1006/bbrc.1995.1958
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Injection of DN-BR mRNA encoding a dominant negative type I receptor for bone morphogenetic protein 4 (BMP4) converted prospective ectoderm into neural tissue in Xenopus animal cap explants, in the absence of expression of mesodermal marker genes. The injected caps expressed a general neural marker NCAM and the forebrain marker opsin. Coinjection of wild-type BMP4 receptor mRNA completely reversed the neuralization by DN-BR. No expression of known neuralizing factors, i.e., noggin and follistatin,was detected in the DN-BR-injected animal caps. Furthermore, neuralization elicited by noggin or 3m, a LIM domain mutant of Xlim-1, was substantially inhibited by co-injection of BMP4 mRNA. Since BMP4 is expressed in the prospective ectoderm during gastrulation, our results suggest that the ventralizing factor BMP4 acts also as a physiological inhibitor of neuralization in the development of Xenopus ectoderm.
引用
收藏
页码:212 / 219
页数:8
相关论文
共 50 条
  • [1] IMMUNODETECTION OF XENOPUS BONE MORPHOGENETIC PROTEIN-4 IN EARLY EMBRYOS
    NISHIMATSU, SI
    TAKEBAYASHI, K
    SUZUKI, A
    MURAKAMI, K
    UENO, N
    GROWTH FACTORS, 1993, 8 (03) : 173 - 176
  • [2] Bone morphogenetic protein-4
    Leong, LM
    Brickell, PM
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1996, 28 (12): : 1293 - 1296
  • [3] BONE MORPHOGENETIC PROTEIN-4 - A VENTRALIZING FACTOR IN EARLY XENOPUS DEVELOPMENT
    DALE, L
    HOWES, G
    PRICE, BMJ
    SMITH, JC
    DEVELOPMENT, 1992, 115 (02): : 573 - 585
  • [4] Interaction between soluble type I receptor for bone morphogenetic protein and bone morphogenetic protein-4
    Natsume, T
    Tomita, S
    Iemura, S
    Kinto, N
    Yamaguchi, A
    Ueno, N
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (17) : 11535 - 11540
  • [5] Bone morphogenetic protein-4 and bone morphogenetic protein receptors expressions in the adult rat eye
    Maruyama-Koide, Yuka
    Mikawa, Sumiko
    Sasaki, Takeshi
    Sato, Kohji
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2017, 61 (03): : 178 - 185
  • [6] Nigrostriatal alterations in bone morphogenetic protein receptor II dominant negative mice
    Chou, J.
    Harvey, B. K.
    Ebendal, T.
    Hoffer, B.
    Wang, Y.
    RECONSTRUCTIVE NEUROSURGERY, 2008, 101 : 93 - +
  • [7] A DOMINANT-NEGATIVE PDGF RECEPTOR INHIBITS GASTRULATION OF XENOPUS-LAEVIS
    ATALIOTIS, P
    SYMES, K
    CHOU, M
    HO, L
    MERCOLA, M
    DEVELOPMENTAL BIOLOGY, 1995, 170 (02) : 749 - 749
  • [8] Bone morphogenetic protein-4 control of pituitary pathophysiology
    Giacomini, Damiana
    Paez-Pereda, Marcelo
    Theodoropoulou, Marily
    Gerez, Juan
    Nagashima, Alberto Carbia
    Chervin, Alberto
    Berner, Silvia
    Labeur, Marta
    Refojo, Damian
    Renner, Ulrich
    Stalla, Gunter K.
    Arzt, Eduardo
    PITUITARY TODAY: MOLECULAR, PHYSIOLOGICAL AND CLINICAL ASPECTS, 2006, 35 : 22 - 31
  • [9] Bone morphogenetic protein-4, a novel modulator of melanogenesis
    Yaar, Mina
    Wu, Christina
    Park, Hee-Young
    Panova, Izabela
    Schutz, Gunther
    Gilchrest, Barbara A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (35) : 25307 - 25314
  • [10] A role for bone morphogenetic protein-4 in adipocyte development
    Bowers, Robert R.
    Lane, M. Daniel
    CELL CYCLE, 2007, 6 (04) : 385 - 389